Wieland Douglas Scott 4
4 · CYTRX CORP · Filed Dec 11, 2012
Insider Transaction Report
Form 4
CYTRX CORPCYTR
Wieland Douglas Scott
Sr. VP - Drug Development
Transactions
- Award
Stock Option(right to buy)
2012-12-10+100,000→ 100,000 totalExercise: $1.83Exp: 2022-12-09→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Stock Option vests monthly for 36 months beginning January 10, 2013, provided Reporting Person remains in continuous employ of Issuer.